Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

What Makes a “Best Doctor” Best?

Christina Picciano  |  Issue: February 2011  |  February 12, 2011

What Makes a

Standing in line at the supermarket, it is hard to ignore the flood of physician rankings—“Top Docs,” “Best Physicians in…,” “Most Influential Doctors”—that dominate magazine and newspaper covers. Yet, with the many roles and responsibilities that a physician must assume, along with the varying factors that have contributed to his or her establishment, including education, training, academia, and so forth, there is no exact formula for determining precisely what makes a “Best Doctor” best. Championing objectivity, independence, and rigorous physician selection, data analytics companies, healthcare research publishers, and consumer surveyors—including those interviewed here, Qforma, Castle Connolly Medical Limited, and Consumer Reports Health—each have their own approach in ranking physicians across the country.

Qforma: Data Crunching

Qforma, an analytics and predictive modeling company focused on the health sciences industry, analyzes physician location, practice information, patient volume, social and referral networks, hospital affiliation, prescribing and procedural activity, initial education, continuing scholarship, and persistence in academia. Kelly D. Myers, CEO of Qforma, says, “Unlike standard best-doctor lists compiled by opinion-based surveys, the Qforma analysis represent[s] an objective approach by examining data to reveal, on a local level, which physicians appear to be influential amongst their peers in their regions.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Providing an online database that allows public access to their list of “Most Influential Doctors,” Qforma utilizes their staff of mathematicians, physicists, and computer programmers in conjunction with advanced analytic technology to gather and integrate data from differing sources to identify significant trends in physician influence and valued attributes. Qforma’s recent expansion of their database to include experts in chronic pain, osteoporosis, and rheumatoid arthritis marks an increasing recognition of rheumatologists and their discipline. “As data miners and analytics professionals,” Myers states, “it is Qforma’s business to understand the trends taking place in the health sciences industry. In recent years, rheumatology has seen incredible progress leading to breakthrough understanding of rheumatic diseases. Specialists in this area are, therefore, of particular interest. We added rheumatoid arthritis to the MID database because this chronic disease affects 1.3 million Americans.”

In recent years, rheumatology has seen incredible progress leading to breakthrough understanding of rheumatic diseases. … We added rheumatoid arthritis to the MID database because this chronic disease affects 1.3 million Americans.

—Kelly D. Myers

Pleased with Qforma’s inclusion of rheumatologists, Richard S. Panush, MD, professor of medicine in the division of rheumatology at Keck School of Medicine at the University of Southern California in Los Angeles, believes that this type of distinction is long overdue for rheumatologists and reflects the growing attention and stature the specialty has achieved. “I can remember when rheumatology was the boring stepsister of medical specialties,” Dr. Panush says. “All the funding, publicity, and media attention went to cardiology and cancer, understandably, because there’s trauma. Our [rheumatic] diseases disable, our diseases cause incredible social and economic loss, our diseases make use of people’s lives.”

Castle Connolly: Nominations and Interviews

Castle Connolly Medical Limited, a healthcare research and publishing firm established exclusively to identify top doctors, considers education, residency, board certification, fellowships, hospital affiliation and leadership positions, scholarly appointments, disciplinary history, and professional reputation as criteria for determining physician rank.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice SupportQuality Assurance/Improvement Tagged with:dataphysicianPrimary Care Physiciansrankingrheumatologist

Related Articles

    Consumers Add Perspective to Arthritis Research

    November 1, 2006

    It has been my distinct pleasure to work with consumer collaborators—people living with arthritis—on research projects, advisory boards, and review panels, in consensus meetings to establish research agendas, and as co-educators in health professional programs. Those I work with have chosen the term “consumer collaborator” to reflect their contribution to and eventual use of our partnerships, although others might call them patients or clients.

    U.S. Doctor Group Calls for Ban on Drug Advertising to Consumers

    November 19, 2015

    (Reuters)—The American Medical Association on Tuesday called for a ban on advertising prescription drugs and medical devices directly to consumers, saying the ads drive patients to demand expensive treatments over less costly ones that are also effective. The influential doctors’ group said the new policy reflects physicians’ concerns that marketing spending on a proliferation of…

    Patients Get Mixed Reactions from Docs over Mail-Ordered Genetic Tests

    March 3, 2016

    (Reuters Health)—Patients who order direct-to-consumer genetic tests report mixed experiences when they take the results to their doctors, a new study found. About a quarter of people who ordered direct-to-consumer genetic testing from such companies as 23andMe reported discussing the results with their primary care doctors. But nearly one in five were not at all…

    Choosing Wisely: Recommendations from Medical Specialties Beyond Rheumatology

    October 1, 2014

    Practice gems that may help rheumatologists avoid performing costly patient tests, procedures of limited use

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences